StockData
Cencora, Inc. logo

Cencora, Inc.

CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 15/3019% above fair value
$339.09−2.16 (-0.63%)

Close on Nov 20, 2026Market cap $64.71BP/E 25.2Yield 0.65%

Cencora Net Cash Used in Investing Activities (GAAP, $M) by Quarter

Net Cash Used in Investing Activities (GAAP, $M) ($M)

Periods

Cencora Net Cash Used in Investing Activities (GAAP, $M): -$386M in Q4 FY26, up 20.0% from a year earlier.

Latest, Q4 FY26
-386
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
+20.0%
-322 in Q4 FY25
History
69 quarters
Since Q4 FY08
Sources
65
Documents cited below

Where the Q4 FY26 figure comes from

Calculated from reported figures: Q4 = full year (8-K $-5,800.6M) − nine months (Q1–Q3 10-Q $-5,414.4M)

Source: Cencora Form 8-K (filed 2026-11-04, acc 0001140859-26-000038) ↗

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Cash Used in Investing Activities (GAAP, $M) ($M)Year on yearSource
Q4 FY26CQ3 2026Sep 30, 2026-386+20.0%Cencora Form 8-K (filed 2026-11-04, acc 0001140859-26-000038) ↗
Q3 FY26CQ2 2026Jun 30, 2026-240+2.3%Cencora Form 10-Q (filed 2026-08-05, acc 0001140859-26-000034) ↗
Q2 FY26CQ1 2026Mar 31, 2026-4,875+19.6%Cencora Form 10-Q (filed 2026-05-06, acc 0001140859-26-000020) ↗
Q1 FY26CQ4 2025Dec 31, 2025-299-12.7%Cencora Form 10-Q (filed 2026-02-04, acc 0001140859-26-000006) ↗
Q4 FY25CQ3 2025Sep 30, 2025-322+33.1%Cencora Form 10-K (filed 2025-11-25, acc 0001140859-25-000131) ↗
Q3 FY25CQ2 2025Jun 30, 2025-235+63.1%Cencora Form 10-Q (filed 2025-08-06, acc 0001140859-25-000122) ↗
Q2 FY25CQ1 2025Mar 31, 2025-4,078+2,349.0%Cencora Form 10-Q (filed 2025-05-07, acc 0001140859-25-000083) ↗
Q1 FY25CQ4 2024Dec 31, 2024-343+421.3%Cencora Form 10-Q (filed 2025-02-05, acc 0001140859-25-000034) ↗
Q4 FY24CQ3 2024Sep 30, 2024-242+31.9%Cencora Form 10-K (filed 2024-11-26, acc 0001140859-24-000177) ↗
Q3 FY24CQ2 2024Jun 30, 2024-144-82.4%Cencora Form 10-Q (filed 2024-07-31, acc 0001140859-24-000119) ↗
Q2 FY24CQ1 2024Mar 31, 2024-167+87.7%Cencora Form 10-Q (filed 2024-05-01, acc 0001140859-24-000072) ↗
Q1 FY24CQ4 2023Dec 31, 2023-65.8-95.6%Cencora Form 10-Q (filed 2024-01-31, acc 0001140859-24-000019) ↗
Q4 FY23CQ3 2023Sep 30, 2023-183+5.0%Cencora Form 10-K (filed 2023-11-21, acc 0001140859-23-000197) ↗
Q3 FY23CQ2 2023Jun 30, 2023-819-670.8%Cencora Form 10-Q (filed 2023-08-02, acc 0001140859-23-000116) ↗
Q2 FY23CQ1 2023Mar 31, 2023-88.7-54.3%Cencora Form 10-Q (filed 2023-05-02, acc 0001140859-23-000084) ↗
Q1 FY23CQ4 2022Dec 31, 2022-1,511+956.0%Cencora Form 10-Q (filed 2023-02-01, acc 0001140859-23-000027) ↗

Cite this data

StockData. (2026). Cencora Net Cash Used in Investing Activities (GAAP, $M) ($M), quarterly Q4 FY08–Q4 FY26 [Data set]. Compiled from Cencora SEC filings and investor materials. https://stockdatahq.com/stocks/cor/kpis/fin-db-icf

See every metric in the Cencora KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?